The expression of murine double minute 2 is a favorable prognostic marker in esophageal squamous cell carcinoma without p53 protein accumulation

Annals of Surgical Oncology

Volumn 9, Issue 5, 2002, Pages 450-456

  Saito, Hiroaki ^a   Tsujitani, Shunichi ^a   Oka, Shinichi ^a   Ikeguchi, Masahide ^a   Maeta, Michio ^a   Kaibara, Nobuaki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Esophageal carcinoma; Ki 67; Murine double minute 2; P53

Indexed keywords

KI 67 ANTIGEN; ONCOPROTEIN; PROTEIN MDM2; PROTEIN P53;

ADULT; AGED; ARTICLE; CORRELATION ANALYSIS; ESOPHAGUS CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; NUCLEAR PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036282464     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/aso.2002.9.5.450     Document Type: Article

References (32)

1. Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line
2. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line
3. Amplification of a gene encoding a p53-associated protein in human sarcomas
4. Physical and functional interaction between wild-type p53 and mdm2 proteins
5. Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes
6. Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of MDM-2 amplification in human esophageal carcinomas
7. Genetic alterations in patients with esophageal cancer with short- and long-term survival rates after curative esophagectomy
8. Significance of retinoblastoma and mdm2 gene expression as prognostic markers for soft-tissue sarcoma
9. Clinicopathologic significance of the expression of mutated p53 protein and the proliferative activity of cancer cells in patients with esophageal squamous cell carcinoma
10. MDM2 gene amplification in bone and soft-tissue tumors: Association with tumor progression in differentiated adipose-tissue tumors
11. Mdm2 gene alterations and mdm2 protein expression in breast carcinomas
12. p21/waf1/cip1 and mdm-2 expression in breast carcinoma patients as related to prognosis
13. DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours
14. Oncogene amplification in urothelial cancer with p53 gene mutation or MDM2 amplification
15. Infrequent MDM-2 gene amplification and absence of gross WAF-1 gene alterations in nasopharyngeal carcinoma
16. p53 and MDM2 expression in oral squamous call carcinoma
17. MDM-2 oncoprotein overexpression in laryngeal squamous cell carcinoma: Association with wild-type p53 accumulation
18. MDM2 gene amplification and expression in non-small-cell lung cancer: Immunohistochemical expression of its protein is a favorable prognostic marker in patients without p53 protein accumulation
19. Altered patterns of MDM2 and TP53 expression in human bladder cancer
20. Immunohistochemical and molecular evaluation of the mdm-2 gene product in bronchogenic carcinoma
21. DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours
22. Mdm2 mRNA expression is associated with survival in ovarian cancer
23. The expression of the MDM2 gene, a p53 binding protein, in thyroid carcinogenesis
24. Infrequency of MDM-2 gene amplification in pediatric solid tumors and lack of association with p53 mutations in adult squamous cell carcinomas
25. Amplification of the MDM-2 gene in human breast cancer and its association with MDM-2 and p53 protein status
26. Molecular abnormalities of MDM-2 and p53 genes in adult soft tissue sarcoma
27. Overexpression of the MDM-2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene
28. Enhanced translation: A novel mechanism of MDM-2 oncogene overexpression identified in human tumor cells
29. The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma
30. p53AIPI, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53
31. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia